Strides Pharma Science Ltd Quarterly Results
Q1 FY26-27 Results Summary
Revenue
The revenue stands at ₹1,265.41 crore, reflecting a quarter-on-quarter *(QoQ) decrease of 4.39 per cent from ₹1,323.47 crore. This corresponds to a year-on-year *(YoY) growth of 13.01 per cent.
Operating Profit
Operating Profit stands at ₹228.49 crore, reflecting a quarter-on-quarter *(QoQ) decrease of 2.06 per cent from ₹233.30 crore. This corresponds to a year-on-year *(YoY) growth of 8.96 per cent.
PBDT
PBDT stands at ₹256.02 crore, reflecting a quarter-on-quarter *(QoQ) increase of 27.18 per cent from ₹201.30 crore. This corresponds to a year-on-year *(YoY) growth of 49.77 per cent.
Profit Before Tax
Profit Before Tax stands at ₹199.62 crore, reflecting a quarter-on-quarter *(QoQ) increase of 34.83 per cent from ₹148.05 crore. This corresponds to a year-on-year *(YoY) growth of 63.56 per cent.
Net Profit
Net Profit stands at ₹165.49 crore, reflecting a quarter-on-quarter *(QoQ) increase of 28.01 per cent from ₹129.28 crore. This represents a 56.71 per cent year-on-year *(YoY) growth for the same year.
- YoY compares a quarter to the same period last year, and QoQ compares it to the previous quarter.
Strides Pharma Science Ltd News
Strides Pharma Science Ltd Earnings
- YOY
- QOQ
Strides Pharma Science Ltd Earning Charts
Revenue from Operations
in ₹ cr
EBITDA
in ₹ cr
Profit before Tax
in ₹ cr
Net Profit
in ₹ cr
Strides Pharma Science Ltd Research Reports
| Action | Target Price (₹) | Broker | Date | Reports |
|---|---|---|---|---|
| Data Not Found | ||||
Strides Pharma Science Ltd Financial Reports
Strides Pharma Science Ltd Stock Prices Compare with Peers
| Company | 1 Day | 1 Week | 1 month | 3 month | 6 month | 1 Year |
|---|---|---|---|---|---|---|
| Strides Pharma | -2.61% | -5.94% | 2.81% | -3.90% | 10.34% | 30.36% |
| Corona Remedies | -3.22% | -1.17% | -4.44% | -0.30% | 36.77% | 41.24% |
| Blue Jet Health | 1.13% | -2.69% | -6.41% | -2.24% | 49.59% | -18.34% |
| Viyash Scientific | -1.61% | -3.74% | -11.03% | -21.21% | 18.57% | 14.87% |
| P & G Health Ltd | -3.95% | -0.77% | -6.91% | -15.68% | 11.51% | -14.40% |
| Aarti Pharma | 1.50% | 5.72% | 11.59% | 36.84% | 48.86% | 16.67% |
| Sanofi Consumer | -0.71% | -4.97% | -10.32% | -18.36% | -18.63% | -21.10% |
Company Info
Company Information
Chairman & Non Executive Dir. : Arun Kumar
Group CEO & Executive Director : Badree Komandur
Executive Director & COO : VENKATA SEETHARAMA RAJU PAKALAPATI
Independent Non Exe. Director : Kausalya Santhanam
Independent Non Exe. Director : Mukta Malik Arora
Independent Non Exe. Director : Subir Chakraborty
Independent Non Exe. Director : Homi R Khusrokhan
Independent Non Exe. Director : Ameet Hariani
Company Sec. & Compli. Officer : Manjula Ramamurthy